|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquired_by
|
gptkb:Abbott_Laboratories
|
|
gptkbp:acquisition
|
gptkb:Abbott_Laboratories
multiple companies
$5.3 billion
|
|
gptkbp:acquisition_year
|
gptkb:2017
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:brand_recognition
|
strong in diagnostics
|
|
gptkbp:business_model
|
B2 B and B2 C
|
|
gptkbp:categories
|
infectious disease, cardiology, toxicology
|
|
gptkbp:ceo
|
R. Cohen
|
|
gptkbp:certification
|
gptkb:CLIA
|
|
gptkbp:clinical_trial
|
conducted globally
|
|
gptkbp:community_involvement
|
health initiatives
|
|
gptkbp:competitors
|
gptkb:Abbott_Laboratories
gptkb:Roche_Diagnostics
gptkb:Thermo_Fisher_Scientific
gptkb:Siemens_Healthineers
|
|
gptkbp:customer_base
|
hospitals and clinics
|
|
gptkbp:customer_support
|
24/7 service
|
|
gptkbp:divisions
|
gptkb:Alere_Toxicology
|
|
gptkbp:employees
|
Approximately 5,000
approximately 6,000
|
|
gptkbp:financial_performance
|
strong growth
|
|
gptkbp:focus
|
rapid diagnostics
|
|
gptkbp:founded
|
gptkb:1991
gptkb:1999
|
|
gptkbp:founder
|
gptkb:Ron_Cohen
|
|
gptkbp:headquarters
|
gptkb:United_States
gptkb:Waltham,_Massachusetts
Waltham, MA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Alere Inc.
|
|
gptkbp:industry
|
Healthcare
healthcare
|
|
gptkbp:innovation
|
new diagnostic technologies
|
|
gptkbp:invention
|
numerous in diagnostics
|
|
gptkbp:key_people
|
gptkb:Ron_Cohen
|
|
gptkbp:market
|
global
|
|
gptkbp:market_position
|
international
|
|
gptkbp:marketing_strategy
|
focus on emerging markets
|
|
gptkbp:mission
|
improve patient outcomes
|
|
gptkbp:parent_company
|
gptkb:Abbott_Laboratories
|
|
gptkbp:partnerships
|
research institutions
various healthcare organizations
with NGOs
|
|
gptkbp:products
|
diagnostic tests
Diagnostic tests
|
|
gptkbp:provides_guidance_on
|
developed with experts
|
|
gptkbp:reach
|
over 100 countries
|
|
gptkbp:regulatory_compliance
|
FDA approved
|
|
gptkbp:research_and_development
|
significant investment
|
|
gptkbp:revenue
|
$1.5 billion (2015)
$2 billion (2015)
|
|
gptkbp:services
|
Point-of-care testing
point-of-care testing
|
|
gptkbp:social_responsibility
|
health education initiatives
|
|
gptkbp:specialization
|
infectious disease testing
|
|
gptkbp:stock_symbol
|
ALR
|
|
gptkbp:strategic_goals
|
expand product line
|
|
gptkbp:subsidiary
|
gptkb:Alere_Health
|
|
gptkbp:supply_chain
|
efficient and reliable
|
|
gptkbp:sustainability_practices
|
environmental responsibility
|
|
gptkbp:technology
|
point-of-care devices
|
|
gptkbp:traded_on
|
gptkb:NYSE
|
|
gptkbp:training
|
ongoing development programs
|
|
gptkbp:training_programs
|
for healthcare professionals
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:user_feedback
|
integrated into product development
|
|
gptkbp:values
|
integrity and innovation
|
|
gptkbp:vision
|
leading diagnostics company
|
|
gptkbp:website
|
www.alere.com
|
|
gptkbp:bfsParent
|
gptkb:Abbott
|
|
gptkbp:bfsLayer
|
4
|